Detailed information for compound 1256669

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 404.493 | Formula: C23H30F2N2O2
  • H donors: 3 H acceptors: 2 LogP: 3.88 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(=O)N[C@H]([C@@H](CNCc1cccc(c1)C(C)(C)C)O)Cc1cc(F)cc(c1)F
  • InChi: 1S/C23H30F2N2O2/c1-15(28)27-21(11-17-9-19(24)12-20(25)10-17)22(29)14-26-13-16-6-5-7-18(8-16)23(2,3)4/h5-10,12,21-22,26,29H,11,13-14H2,1-4H3,(H,27,28)/t21-,22+/m0/s1
  • InChiKey: GUUXSDASFBPWFQ-FCHUYYIVSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens cathepsin D Starlite/ChEMBL References
Homo sapiens beta-site APP-cleaving enzyme 1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Plasmodium falciparum plasmepsin IV Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma mansoni subfamily A1A unassigned peptidase (A01 family) Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma japonicum Cathepsin D precursor, putative Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium falciparum plasmepsin VI Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma mansoni cathepsin D (A01 family) Get druggable targets OG5_126885 All targets in OG5_126885
Toxoplasma gondii aspartyl protease ASP1 Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma mansoni memapsin-2 (A01 family) Get druggable targets OG5_135830 All targets in OG5_135830
Plasmodium yoelii plasmepsin Get druggable targets OG5_126885 All targets in OG5_126885
Theileria parva pepsinogen, putative Get druggable targets OG5_126885 All targets in OG5_126885
Trichomonas vaginalis Clan AA, family A1, cathepsin D-like aspartic peptidase Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium vivax plasmepsin IV, putative Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium yoelii hypothetical protein Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium knowlesi aspartyl protease, putative Get druggable targets OG5_126885 All targets in OG5_126885
Neospora caninum Renin, related Get druggable targets OG5_126885 All targets in OG5_126885
Loa Loa (eye worm) aspartic protease BmAsp-2 Get druggable targets OG5_126885 All targets in OG5_126885
Candida albicans vacuolar aspartic proteinase precursor similar to S. cerevisiae PEP4 (YPL154C) Get druggable targets OG5_126885 All targets in OG5_126885
Echinococcus multilocularis cathepsin d (lysosomal aspartyl protease) Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium berghei plasmepsin VI Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium falciparum plasmepsin I Get druggable targets OG5_126885 All targets in OG5_126885
Neospora caninum Pepsinogen A1, related Get druggable targets OG5_126885 All targets in OG5_126885
Candida albicans vacuolar aspartic proteinase precursor similar to S. cerevisiae PEP4 (YPL154C) Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium yoelii hypothetical protein Get druggable targets OG5_126885 All targets in OG5_126885
Babesia bovis eukaryotic aspartyl protease family protein Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium falciparum plasmepsin II Get druggable targets OG5_126885 All targets in OG5_126885
Echinococcus granulosus cathepsin d lysosomal aspartyl protease Get druggable targets OG5_126885 All targets in OG5_126885
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium vivax aspartyl proteinase, putative Get druggable targets OG5_126885 All targets in OG5_126885
Toxoplasma gondii aspartyl proteinase (eimepsin), putative Get druggable targets OG5_126885 All targets in OG5_126885
Theileria parva cathepsin E, putative Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium knowlesi plasmepsin IV, putative Get druggable targets OG5_126885 All targets in OG5_126885
Cryptosporidium parvum membrane bound aspartyl proteinase with a signal peptide plus transmembrane domain Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma japonicum ko:K01379 cathepsin D [EC3.4.23.5], putative Get druggable targets OG5_126885 All targets in OG5_126885
Plasmodium berghei plasmepsin IV Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma mansoni cathepsin D (A01 family) Get druggable targets OG5_126885 All targets in OG5_126885
Schistosoma japonicum ko:K07747 beta-site APP-cleaving enzyme 2 (memapsin 1) [EC3.4.23.45], putative Get druggable targets OG5_135830 All targets in OG5_135830
Cryptosporidium hominis aspartyl protease precursor Get druggable targets OG5_126885 All targets in OG5_126885

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Plasmodium falciparum plasmepsin X cathepsin D 412 aa 339 aa 28.9 %
Plasmodium falciparum plasmepsin VII beta-site APP-cleaving enzyme 1 401 aa 352 aa 21.3 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni cathepsin D (A01 family) 0.0195 0.2382 0.2382
Echinococcus granulosus muscleblind protein 0.0145 0.1572 0.1572
Onchocerca volvulus 0.0303 0.4118 1
Echinococcus multilocularis microtubule associated protein 2 0.0668 1 1
Loa Loa (eye worm) pigment dispersing factor receptor c 0.005 0.0053 0.0129
Echinococcus multilocularis cathepsin d (lysosomal aspartyl protease) 0.008 0.0531 0.0531
Schistosoma mansoni microtubule-associated protein tau 0.0668 1 1
Loa Loa (eye worm) hypothetical protein 0.0145 0.1572 0.3818
Loa Loa (eye worm) hypothetical protein 0.0303 0.4118 1
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.0303 0.4118 0.4118
Plasmodium falciparum plasmepsin VI 0.008 0.0531 1
Plasmodium falciparum plasmepsin IV 0.008 0.0531 1
Echinococcus granulosus cathepsin d lysosomal aspartyl protease 0.008 0.0531 0.0531
Echinococcus multilocularis muscleblind protein 1 0.0145 0.1572 0.1572
Schistosoma mansoni memapsin-2 (A01 family) 0.0535 0.7856 0.7856
Loa Loa (eye worm) aspartic protease BmAsp-2 0.008 0.0531 0.1289
Onchocerca volvulus 0.0264 0.3496 0.8488
Trichomonas vaginalis Clan AA, family A1, cathepsin D-like aspartic peptidase 0.008 0.0531 0.5
Plasmodium falciparum plasmepsin I 0.008 0.0531 1
Toxoplasma gondii PAN domain-containing protein 0.059 0.8736 1
Loa Loa (eye worm) hypothetical protein 0.0145 0.1572 0.3818
Toxoplasma gondii aspartyl protease ASP1 0.008 0.0531 0.0608
Plasmodium vivax aspartyl proteinase, putative 0.008 0.0531 1
Schistosoma mansoni cathepsin D (A01 family) 0.0195 0.2382 0.2382
Plasmodium vivax plasmepsin IV, putative 0.008 0.0531 1
Brugia malayi Calcitonin receptor-like protein seb-1 0.005 0.0053 0.0129
Schistosoma mansoni subfamily A1A unassigned peptidase (A01 family) 0.008 0.0531 0.0531
Loa Loa (eye worm) hypothetical protein 0.008 0.0531 0.1289
Trypanosoma cruzi hypothetical protein, conserved 0.0047 0 0.5
Toxoplasma gondii aspartyl proteinase (eimepsin), putative 0.008 0.0531 0.0608
Loa Loa (eye worm) hypothetical protein 0.005 0.0053 0.0129
Brugia malayi Muscleblind-like protein 0.0145 0.1572 0.3818
Plasmodium falciparum plasmepsin II 0.008 0.0531 1
Echinococcus multilocularis muscleblind protein 0.0145 0.1572 0.1572
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.0303 0.4118 0.4118
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.005 0.0053 0.0129
Toxoplasma gondii PAN domain-containing protein 0.059 0.8736 1
Loa Loa (eye worm) hypothetical protein 0.0303 0.4118 1
Brugia malayi Trypsin family protein 0.0303 0.4118 1
Leishmania major hypothetical protein, conserved 0.0047 0 0.5

Activities

Activity type Activity value Assay description Source Reference
ED50 (binding) = 84 nM Inhibition of BACE1 in HEK293 cells expressing swedish mutant APP FAD isoform ChEMBL. 20833041
IC50 (binding) = 1300 nM Inhibition of recombinant BACE1 purified from Escherichia coli ChEMBL. 20833041
IC50 (binding) > 10000 nM Inhibition of cathepsin-D ChEMBL. 20833041

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.